See more : YDx Innovation Corp. (YDRMF) Income Statement Analysis – Financial Results
Complete financial analysis of Guangzhou Jet Bio-Filtration Co., Ltd. (688026.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Guangzhou Jet Bio-Filtration Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Bosch Limited (BOSCHLTD.BO) Income Statement Analysis – Financial Results
- Qianhe Condiment and Food Co., Ltd. (603027.SS) Income Statement Analysis – Financial Results
- PRECISION.BO Income Statement Analysis – Financial Results
- Chemring Group PLC (CHG.L) Income Statement Analysis – Financial Results
- Antipodes Global Shares (Quoted Managed Fund) (AGX1.AX) Income Statement Analysis – Financial Results
Guangzhou Jet Bio-Filtration Co., Ltd. (688026.SS)
About Guangzhou Jet Bio-Filtration Co., Ltd.
Guangzhou Jet Bio-Filtration Co., Ltd. researches, develops, manufactures, and sells laboratory consumable products. The company's principal products include laboratory consumables, such as pipettes, tissue culture products, centrifuge tubes, filtration products etc.; and analyzers, lab equipment, reagents, gloves, and other products. It provides its products to approximately 50 countries, including the United States, Japan, Canada, Germany, Australia, and South Korea. The company was founded in 2001 and is based in Guangzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 463.10M | 609.82M | 855.66M | 503.93M | 247.50M | 207.48M | 167.04M | 124.02M | 102.79M | 88.26M | 70.02M |
| Cost of Revenue | 321.29M | 415.64M | 497.02M | 270.54M | 136.86M | 115.79M | 91.10M | 70.20M | 60.72M | 55.99M | 37.54M |
| Gross Profit | 141.81M | 194.18M | 358.64M | 233.40M | 110.64M | 91.69M | 75.94M | 53.82M | 42.06M | 32.28M | 32.48M |
| Gross Profit Ratio | 30.62% | 31.84% | 41.91% | 46.32% | 44.70% | 44.19% | 45.46% | 43.40% | 40.92% | 36.57% | 46.38% |
| Research & Development | 28.51M | 37.34M | 43.84M | 23.90M | 12.56M | 8.64M | 7.87M | 7.62M | 0.00 | 0.00 | 6.10M |
| General & Administrative | 7.55M | 10.49M | 11.98M | 5.49M | 7.78M | 8.38M | 8.90M | 6.97M | 15.48M | 14.74M | 10.97M |
| Selling & Marketing | 11.65M | 25.16M | 24.38M | 22.22M | 17.86M | 15.40M | 13.33M | 12.23M | 8.73M | 8.05M | 6.53M |
| SG&A | 19.19M | 35.66M | 36.35M | 27.71M | 25.63M | 23.78M | 22.23M | 19.20M | 24.21M | 22.79M | 17.50M |
| Other Expenses | 54.67M | 16.52M | 15.36M | 802.59K | -2.37M | 109.03K | 3.45M | 5.86M | 3.57M | 4.07M | 2.66M |
| Operating Expenses | 102.37M | 89.51M | 95.55M | 52.41M | 35.82M | 29.69M | 28.26M | 28.68M | 25.21M | 23.40M | 18.06M |
| Cost & Expenses | 423.65M | 505.16M | 592.57M | 322.94M | 172.68M | 145.49M | 119.36M | 98.88M | 85.93M | 79.38M | 55.61M |
| Interest Income | 14.38M | 8.14M | 4.82M | 10.81M | 130.13K | 42.75K | 0.00 | 143.83K | 16.77K | 10.64K | 4.93K |
| Interest Expense | 24.91M | 12.85M | 1.09M | 3.06K | 183.54K | 136.04K | 733.75K | 1.60M | 2.82M | 2.34M | 914.37K |
| Depreciation & Amortization | 59.65M | 61.59M | 51.87M | 22.20M | 11.81M | 1.68M | 1.69M | 2.01M | 7.70M | 5.06M | 3.04M |
| EBITDA | 123.67M | 174.27M | 248.79M | 171.35M | 88.38M | 71.71M | 49.57M | 34.04M | 24.55M | 13.94M | 17.46M |
| EBITDA Ratio | 26.70% | 30.59% | 34.68% | 40.36% | 36.36% | 35.95% | 35.34% | 34.18% | 26.25% | 16.72% | 24.85% |
| Operating Income | 39.44M | 96.09M | 210.91M | 148.17M | 76.44M | 61.17M | 43.48M | 24.48M | 13.05M | 5.69M | 12.79M |
| Operating Income Ratio | 8.52% | 15.76% | 24.65% | 29.40% | 30.89% | 29.48% | 26.03% | 19.74% | 12.70% | 6.45% | 18.27% |
| Total Other Income/Expenses | -1.12M | 1.92M | -15.27M | -412.26K | -58.78K | 109.03K | 3.45M | 5.86M | 3.57M | 4.07M | 2.66M |
| Income Before Tax | 38.32M | 98.00M | 195.65M | 147.76M | 76.38M | 61.28M | 46.94M | 30.34M | 16.62M | 9.77M | 15.45M |
| Income Before Tax Ratio | 8.27% | 16.07% | 22.86% | 29.32% | 30.86% | 29.54% | 28.10% | 24.46% | 16.17% | 11.06% | 22.07% |
| Income Tax Expense | 3.22M | 10.31M | 24.49M | 28.39M | 10.23M | 8.50M | 6.81M | 4.50M | 3.19M | 1.62M | 1.90M |
| Net Income | 34.79M | 87.71M | 171.16M | 119.37M | 66.15M | 52.83M | 40.36M | 26.07M | 13.43M | 8.15M | 13.56M |
| Net Income Ratio | 7.51% | 14.38% | 20.00% | 23.69% | 26.73% | 25.47% | 24.16% | 21.02% | 13.07% | 9.23% | 19.36% |
| EPS | 0.25 | 0.62 | 1.22 | 0.85 | 0.47 | 0.54 | 0.41 | 0.26 | 0.23 | 0.14 | 0.33 |
| EPS Diluted | 0.25 | 0.62 | 1.22 | 0.85 | 0.47 | 0.54 | 0.41 | 0.26 | 0.23 | 0.14 | 0.33 |
| Weighted Avg Shares Out | 139.15M | 140.36M | 140.00M | 140.00M | 140.00M | 98.63M | 97.41M | 98.65M | 58.77M | 57.05M | 40.75M |
| Weighted Avg Shares Out (Dil) | 139.15M | 140.36M | 140.00M | 140.00M | 140.00M | 98.63M | 97.41M | 98.65M | 58.77M | 57.05M | 40.75M |
Source: https://incomestatements.info
Category: Stock Reports